Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Shankland, Stuart J  [Clear All Filters]
Journal Article
Shankland SJ, Wessely O. Zoning in on podocytes. Kidney Int. 2022;102(5):966-968.
Shankland SJ, J Jefferson A, Wessely O. Repurposing Drugs for Diseases Associated with Podocyte Dysfunction. Kidney Int. 2023.
Rayner SG, Phong KT, Xue J, Lih D, Shankland SJ, Kelly EJ, Himmelfarb J, Zheng Y. Reconstructing the Human Renal Vascular-Tubular Unit In Vitro. Adv Healthc Mater. 2018:e1801120.
Wessely O, Shankland SJ. The proliferative and the antifibrotic side of PAX2 in tubular repair. Kidney Int. 2022;102(1):12-13.
Naved BA, Bonventre JV, Hubbell JA, Hukriede NA, Humphreys BD, Kesselman C, M Valerius T, McMahon AP, Shankland SJ, Wertheim JA, et al. KIDNEY REPAIR AND REGENERATION: PERSPECTIVES OF THE NIDDK (RE)BUILDING A KIDNEY CONSORTIUM. Kidney Int. 2022.
Kaverina N, R Schweickart A, Chan GCher, Maggiore JC, Eng DG, Zeng Y, McKinzie SR, Perry HS, Ali A, O'Connor C, et al. Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span. Aging (Albany NY). 2023;15.
Wang Y, Eng DG, Kaverina NV, Loretz CJ, Koirala A, Akilesh S, Pippin JW, Shankland SJ. Global transcriptomic changes occur in aged mouse podocytes. Kidney Int. 2020.
Nakagawa N, Xin C, Roach AM, Naiman N, Shankland SJ, Ligresti G, Ren S, Szak S, Gomez IG, Duffield JS. Dicer1 activity in the stromal compartment regulates nephron differentiation and vascular patterning during mammalian kidney organogenesis. Kidney Int. 2015.